The EMSS provides laboratory support for all Cell Culture needs.
EMSS provides some human optical reporter cell lines that have been transfected with GFP, RFP and luciferase for experimental purposes. These cell lines include breast, pancreatic and colon cancers and are bolded;
Cell Lines & Tumor Types Listed Below (bottom of the page).
Services provided include:
1-Large scale culture
2-Mycoplasma screening
3-Consultation & training
4-Bank of tumor cell lines
5-Transfection of adherent cell lines
The EMSS Team can grow these or other established cell lines, and provide all necessary cell culture products, and mycoplasma screening. Regular screening of cell lines for mycoplasma is extremely important. This is especially true when accepting any cell line from an outside source. Mycoplasma can alter virtually every property measured in cell cultures. Working with contaminated cultures may nullify all results. Recommended treatment methods can be provided in cases of mycoplasma contamination. In addition, the EMSS can transfect adherent cell lines. Consultation and training sessions are available. Session topics often range from how to solve contamination problems, to questions about cell growth, to cell culture techniques. Contact us about your topic interests and scheduling opportunities.
To check on the availability of cells provided Contact us
Investigators receiving cell lines must complete a Cell Line Waiver Form.
Human, Murine, & Rat Tumor Models
The model of choice can be used, and assistance is available to help you select the most appropriate model for the investigation agent you are using. Specially requested cell lines or tumor chunks can be brought in-house if a desired model is not listed below. Note that the human optical reporter cell lines are bolded.
New University &/or Cancer Center Clients, please Contact Us.
Investigators receiving cell lines must complete a Cell Line Waiver Form.
|
Human Tumor Xenografts |
|
|
Tumor Types |
Cell Line Name |
|
Breast |
BT-474, MCF7/S, MDA-MB-231, ZR-75-1, MCF7/TAMR-1, MCF7/Mitox, MCF7/D40, MDA-MB-453, MCF7/CMV-Luc, MCF7/eGFP, MDA-MB-231/CMV-Luc, MDA-MB-231/eGFP, MDA-MB-231/eRFP |
|
Burkitt's Lymphoma |
Ramos |
|
Cervix |
|
|
Colon |
|
|
Epidermis |
|
|
Fibrosarcoma |
|
|
Gastrointestinal Stromal Tumor |
GIST882 |
|
Glioblastoma |
|
|
Head & Neck |
HN5 |
|
Leukemia |
HL-60, K562/S, K562/MDR, KG-1, OCI-AML3 |
|
Liver |
|
|
Lung-NSCLC |
|
|
Lung-SCLC |
|
|
Lymphoma |
|
|
Melanoma |
A-375, DH903, JH1308, KD1592, PS1273, WM1791C, LOX IMVI, SB-CL2, MDA-MB-435 |
|
Myeloma |
8226/S, 8226/V, 8228/Dox40, ARH-77, ARHD60 |
|
Neuroblastoma |
|
|
Osteosarcoma |
|
|
Ovarian |
A2780, A2780/ADR, NIH:OVCAR-3 |
|
Pancreatic |
AsPC-1, BxPC-3, CFPAC-1, HPAF-II, |
|
Prostate |
|
|
Renal |
|
|
Sarcoma- Ewing's |
CHP-100 |
|
Uterine Epithelial |
RL 95.2 |
|
Mouse Tumor Xenografts |
|
|
Melanoma |
|
|
Rat Tumor Xenografts |
|
|
Breast |
13762NF |
|
Glioblastoma |
C6 |
Again, New University or Cancer Center Clients, please Contact Us.
Investigators receiving cell lines must complete a Cell Line Waiver Form.